查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2093113

獸用抗菌藥物敏感性檢測市場－2026-2032年全球市場預測

Veterinary Antimicrobial Susceptibility Testing Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸用抗菌藥物敏感性測試市場將成長至 26.6 億美元，複合年成長率為 8.78%。

主要市場統計數據
基準年 2025 14.7億美元
預計年份：2026年 16億美元
預測年份 2032 26.6億美元
複合年成長率 (%) 8.78%

獸用抗菌藥物敏感性測試執行摘要

在獸醫學中，抗菌藥物敏感性試驗（AST）正日益成為動物健康、食品安全和抗菌藥物抗藥性（AMR）管理的關鍵支柱。透過確定伴侶動物、牲畜、水產養殖或家禽中的致病菌對特定抗生素的敏感性或抗藥性，獸醫學中的AST有助於循證治療決策，並減少不必要的抗生素使用。該領域的發展受到國際公認的標準和監測框架的阻礙，包括世界動物衛生組織（OIE）、國際食品轉碼器、各國獸醫診斷標準以及在「同一健康」理念下整合動物、食品、人類和環境數據的AMR監測項目。

將重塑獸醫AST的變革性變化

獸醫抗菌藥物敏感性試驗（AST）領域正經歷從臨時性檢測到常規、與監測相結合的診斷的結構性轉變，強調合理用藥。傳統上，獸醫學中抗生素的處方主要依賴經驗性治療、農場層面的治療方案或延遲的檢測確認。然而，隨著抗菌藥物抗藥性控制計劃、獸醫學中抗生素使用限制、處方管理以及價值鏈保障計劃的實施，這種模式正在改變。這些計劃現在建議在治療決策之前或期間進行細菌培養和藥敏試驗，尤其是在復發性行為感染、群體內集體爆發以及高附加價值生產系統中。

人工智慧 (AI) 對獸醫抗菌藥物敏感性測試 (AST) 的累積影響。

人工智慧 (AI) 正透過數據解讀、工作流程最佳化和改進監測訊息，對整體獸醫學領域的抗菌藥物敏感性試驗 (AST) 產生累積影響。在診斷檢查室中，AI 驅動的影像分析可以輔助菌落識別、抑菌圈測量、生長模式檢測和品管審核，並在系統經過適當檢驗後減少人工操作的差異。機器學習模型還可以幫助識別異常抗藥性表現型、識別潛在的污染或混合培養模式，並優先處理需要確認試驗的分離株。

區域對獸醫學中抗菌藥物敏感性測試（AST）引入的重點見解。

在亞太地區，畜牧業集約化、水產養殖業擴張、伴侶動物醫學發展以及各國採取的抗微生物藥物抗藥性（AMR）措施，正推動著獸用抗生素敏感性檢測技術的進步。儘管該地區各國都在加強對食源性病原體和動物抗生素使用的監測，但先進的都市區檢測實驗室與資源匱乏的農村生產區之間，診斷能力仍有顯著差距。該地區的大規模家禽、生豬、​​乳牛和水產養殖業對標準化的抗生素敏感性檢測（AST）有著強烈的需求，以支持疾病管理和合理使用抗生素。

獸醫抗菌藥物敏感性測試（AST）相關人員的關鍵群體分析。

在東協獸醫領域，抗菌藥物敏感性試驗（AST）的優先事項與家禽、生豬、​​水產養殖和食品安全計劃密切相關，成員國正日益將動物健康監測與其國家抗菌藥物抗藥性（AMR）戰略相協調。儘管由於檢測設施基礎設施、監管執法和農場生物安全方面的差異，AST 的採用情況有所不同，但區域貿易和食品出口的要求仍在推動標準化檢測和報告的實施。

來自影響獸醫領域AST需求的關鍵國家的見解

在美國，已建立起完善的獸醫診斷檢查室網路和成熟的抗菌藥物抗藥性（AMR）監測項目，用於在肉類生產、零售和人類健康接觸點評估抗藥性細菌。這使得合理使用方案高度依賴品質有保證的抗菌藥物敏感性試驗（AST）。加拿大同樣重視綜合監測、獸醫監管和謹慎用藥政策，而墨西哥則在畜牧生產、食品安全和跨境貿易方面加強其獸醫診斷能力。在巴西，家禽、牛肉和豬肉等大規模生產部門發揮著至關重要的作用，獸醫抗菌藥物敏感性試驗在確保出口安全、管理牲畜健康和監測通用感染疾病發揮關鍵作用。

為獸醫動物穩定系統 (AST) 領導者提供的實用建議

業界領導者應優先考慮符合公認標準、品管要求和臨床適用解讀標準的、經過檢驗的獸醫專用藥敏試驗（AST）工作流程。實驗室和診斷解決方案提供者可以透過提供物種適用的抗菌藥物組合、清晰的報告格式以及區​​分臨床斷點、流行病學臨界值和抗藥性標記的決策支援來促進這些工作流程的採用。保持對藥敏試驗結果的信心需要對員工培訓、技能評估和實驗室認證進行投入。

基於證據的獸醫抗菌藥物敏感性試驗（AST）分析的調查方法

穩健的獸用抗菌藥物敏感性試驗分析調查方法需要結合二次調查、專家檢驗和系統性證據審查。可靠的資訊來源包括同行評審的獸醫微生物學期刊、抗菌藥物抗藥性監測報告、監管指南、檢查室標準、國家行動計劃、食品安全機構以及國際「同一健康」框架。證據的評估應考慮地域相關性、物種特異性、病原體覆蓋範圍、檢測方法有效性以及與現有獸醫決策標準的一致性。

結論：獸醫AST是「同一健康」的強制性要求

在獸醫學中，抗菌藥物敏感性試驗（AST）在負責任的動物護理、食品安全以及基於「同一健康」理念的抗菌藥物抗藥性管理中發揮核心作用。隨著獸醫學從經驗性抗生素使用轉向實證治療，AST為標靶治療、抗藥性監測和合理用藥課責提供了檢查室基礎。標準化方法、獸醫專用標準、數位監測、快速診斷以及經過嚴格檢驗的人工智慧工具正在推動這一領域的變革。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 獸用抗菌藥物敏感性檢測市場：依檢測類型分類

  • 自動化系統
    • 微型掃描系統
    • 鳳凰系統
    • VITEK系統
    • 走開系統
  • 肉湯微量稀釋法
    • 自動化肉湯微量稀釋法
    • 手動肉湯微量稀釋法
  • 紙錠擴散法
  • Etest
  • 分子生物學方法
    • LAMP方法
    • 基於NGS的方法
    • PCR方法
    • 定量PCR方法

第8章：獸用抗菌藥物敏感性測試市場：依動物類型分類

  • 水產養殖
  • 伴侶動物
  • 馬
  • 家畜
  • 家禽

第9章 獸用抗菌藥物敏感性檢測市場：依病原體類型分類

  • 真菌
  • 革蘭氏陰性菌
  • 革蘭氏陽性菌
  • 分枝桿菌

第10章 獸用抗菌藥物敏感性檢測市場：依樣本類型分類

  • 血
  • 牛奶
  • 拭子
  • 組織
  • 尿

第11章 獸用抗菌藥物敏感性檢測市場：依產品類型分類

  • 裝置
    • 自動分析儀
    • 桌面設備
  • 試劑盒和試劑
    • 消耗品
    • 試劑
  • 軟體服務
    • 資料管理軟體
    • 技術支援和諮詢

第12章 獸用抗菌藥物敏感性檢測市場：依最終用戶分類

  • 製藥和生物技術
  • 研究機構
  • 獸醫診斷檢測實驗室
  • 獸醫醫院和診所

第13章 獸用抗菌藥物敏感性檢測市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第14章 獸用抗菌藥物敏感性檢測市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第15章 獸用抗菌藥物敏感性檢測市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Accelerate Diagnostics, Inc.
  • Alifax Srl
  • Alveo Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biogal Galed Laboratories
  • Bioguard Corporation
  • bioMerieux SA
  • Bruker Corporation
  • Condalab SL
  • Creative Diagnostics
  • Eurofins Scientific SE
  • Hardy Diagnostics
  • HiMedia Laboratories Private Limited
  • Liofilchem Srl
  • Mast Group Ltd.
  • Microbiologics, Inc.
  • QIAGEN NV
  • QuantaMatrix Inc.
  • SSI Diagnostica A/S
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.
Product Code: MRR-FD3F12D533B4

The Veterinary Antimicrobial Susceptibility Testing Market is projected to grow by USD 2.66 billion at a CAGR of 8.78% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.47 billion
Estimated Year [2026] USD 1.60 billion
Forecast Year [2032] USD 2.66 billion
CAGR (%) 8.78%

Veterinary Antimicrobial Susceptibility Testing Executive Summary

Veterinary antimicrobial susceptibility testing (AST) is becoming a critical pillar of animal health, food safety, and antimicrobial resistance (AMR) stewardship. By determining whether bacterial pathogens from companion animals, livestock, aquaculture, or poultry are susceptible or resistant to specific antimicrobial agents, veterinary AST supports evidence-based treatment decisions and helps reduce unnecessary antibiotic use. The field is shaped by internationally recognized standards and surveillance frameworks, including guidance from the World Organisation for Animal Health, Codex Alimentarius, national veterinary diagnostic standards, and integrated AMR monitoring programs that connect animal, food, human, and environmental data under a One Health approach.

The relevance of veterinary antimicrobial susceptibility testing has increased as resistant zoonotic and foodborne bacteria such as Salmonella, Campylobacter, Escherichia coli, Staphylococcus pseudintermedius, Streptococcus suis, and Pasteurella species remain a concern across animal production systems and clinical veterinary practice. Laboratories are expanding the use of broth microdilution, disk diffusion, agar dilution, gradient diffusion, automated phenotypic systems, and molecular assays to generate actionable results. At the same time, veterinary clinicians, producers, regulators, and diagnostic networks are demanding faster turnaround times, standardized interpretive criteria, quality-controlled workflows, and data interoperability to support responsible antimicrobial use.

Transformative Shifts Reshaping Veterinary AST

The veterinary AST landscape is undergoing a structural shift from episodic testing toward routine, surveillance-linked, and stewardship-oriented diagnostics. Historically, many antimicrobial decisions in veterinary care relied on empirical therapy, farm-level treatment protocols, or delayed laboratory confirmation. This model is changing as AMR action plans, veterinary antimicrobial use restrictions, prescription oversight, and food chain assurance programs encourage culture and susceptibility testing before or during treatment decisions, particularly for recurrent infections, herd outbreaks, and high-value production systems.

A second transformation is the movement toward harmonized standards and species-relevant breakpoints. Veterinary AST has long faced challenges where human clinical breakpoints were used inappropriately for animal pathogens or where interpretive criteria were unavailable for specific host-pathogen-drug combinations. Current best practice increasingly emphasizes validated veterinary breakpoints, epidemiological cutoff values, quality control organisms, and standardized reporting language that reflects pharmacokinetics, pharmacodynamics, tissue distribution, and route of administration in target species.

The third major shift is digitalization. Laboratory information systems, electronic veterinary medical records, and AMR surveillance platforms are enabling structured reporting of isolate-level susceptibility results. This supports longitudinal resistance tracking, antimicrobial stewardship benchmarking, outbreak investigation, and risk-based interventions in livestock and companion animal settings. The growing use of rapid diagnostics, molecular resistance marker detection, and automated susceptibility platforms is also reshaping expectations around speed, accuracy, and decision support.

Cumulative Impact of Artificial Intelligence on Veterinary AST

Artificial intelligence is beginning to create cumulative impact across veterinary antimicrobial susceptibility testing by improving data interpretation, workflow efficiency, and surveillance intelligence. In diagnostic laboratories, AI-enabled image analysis can support colony recognition, inhibition zone reading, growth pattern detection, and quality control review, reducing manual variability when systems are properly validated. Machine learning models can also help flag unusual resistance phenotypes, identify likely contamination or mixed culture patterns, and prioritize isolates requiring confirmatory testing.

In clinical and production settings, AI can strengthen antimicrobial stewardship by combining AST results with animal species, disease syndrome, prior treatment history, farm management data, vaccination status, and regional resistance trends. This creates an opportunity for decision support tools that recommend when testing is warranted, which antimicrobial panels are most appropriate, and how results should be interpreted in the context of veterinary guidelines. For food animal systems, AI can help detect early AMR signals across farms, slaughter points, feedlot networks, and diagnostic submissions.

However, the value of AI in veterinary AST depends on verified datasets, standardized metadata, transparent model validation, and governance that prevents overreliance on algorithmic outputs. Resistance prediction from genomic data remains promising but must be connected to phenotypic confirmation, clinically relevant breakpoints, and species-specific treatment outcomes. The most defensible AI applications are those that augment trained microbiologists and veterinarians rather than replace laboratory quality systems, antimicrobial stewardship principles, or professional clinical judgment.

Key Regional Insights Across Veterinary AST Adoption

Asia-Pacific is advancing veterinary antimicrobial susceptibility testing through a combination of livestock intensification, aquaculture expansion, companion animal healthcare growth, and national AMR action plans. Countries in the region are strengthening surveillance of foodborne pathogens and antimicrobial use in animals, while diagnostic capacity varies widely between advanced urban laboratories and resource-constrained rural production areas. The region's large poultry, swine, dairy, and aquaculture sectors create strong demand for standardized AST that can support disease control and prudent antimicrobial use.

North America has mature veterinary diagnostic infrastructure, established antimicrobial stewardship programs, and integrated monitoring of resistant bacteria from food animals, retail meat, and humans. The United States and Canada emphasize laboratory quality assurance, veterinary oversight of medically important antimicrobials, and surveillance-linked reporting, supporting adoption of validated phenotypic and molecular AST workflows. Latin America is strengthening veterinary AST through food export requirements, poultry and beef production monitoring, and public health attention to zoonotic resistance, although uneven laboratory access and standardization remain important operational challenges.

Europe is characterized by strong regulatory pressure on antimicrobial use in animals, coordinated AMR monitoring, and extensive implementation of One Health surveillance principles. Restrictions on routine prophylactic use, emphasis on veterinary prescription accountability, and harmonized reporting frameworks support consistent demand for AST in both food animal and companion animal practice. In the Middle East, veterinary AST adoption is shaped by food security priorities, intensive poultry and dairy production, equine medicine, and growing companion animal care, with GCC countries investing in laboratory modernization and biosecurity. Across Africa, veterinary AST is gaining importance as countries address transboundary animal diseases, food safety, zoonotic infections, and antimicrobial stewardship, but capacity building, access to quality-assured laboratories, and workforce training remain essential to improve diagnostic coverage.

Key Group Insights for Veterinary AST Stakeholders

ASEAN's veterinary antimicrobial susceptibility testing priorities are closely linked to poultry, swine, aquaculture, and food safety programs, with member states increasingly aligning animal health surveillance with national AMR strategies. Differences in laboratory infrastructure, regulatory enforcement, and farm biosecurity create variability in AST adoption, but regional trade and food export requirements continue to encourage standardized testing and reporting.

The GCC is advancing veterinary AST through investments in food security, dairy and poultry production, camel and equine health, and centralized laboratory capabilities. Demand is reinforced by import controls, biosecurity initiatives, and the need to manage infectious disease risks in intensive and high-value animal populations. The European Union represents one of the most structured environments for veterinary AST due to harmonized AMR monitoring, restrictions on veterinary antimicrobial use, and strong emphasis on One Health data integration across animal, food, and human health sectors.

BRICS countries represent diverse but influential veterinary AST environments due to their large livestock populations, expanding veterinary services, and growing role in global food supply. China, India, Brazil, Russia, and South Africa face different challenges, ranging from high production density and mixed farming systems to diagnostic access gaps and regional surveillance variability. G7 countries generally have advanced laboratory networks, veterinary prescription controls, and research-driven stewardship programs that support high-quality AST implementation. NATO member countries, many of which overlap with high-income European and North American systems, show strong alignment around biosecurity, food safety, and public health preparedness, making veterinary AST relevant not only to clinical care but also to resilience against zoonotic and transboundary disease threats.

Key Country Insights Shaping Veterinary AST Demand

The United States has a well-developed veterinary diagnostic laboratory network and established AMR surveillance programs that evaluate resistant bacteria across food animals, retail meat, and human health interfaces, supporting high reliance on quality-assured AST in stewardship programs. Canada similarly emphasizes integrated surveillance, veterinary oversight, and prudent use policies, while Mexico is strengthening veterinary diagnostic capacity in the context of livestock production, food safety, and cross-border trade. Brazil's large poultry, beef, and swine sectors make veterinary AST important for export assurance, herd health, and zoonotic pathogen monitoring.

In Europe, the United Kingdom, Germany, France, Italy, and Spain operate under strong antimicrobial stewardship expectations and regulatory controls that encourage responsible prescribing and laboratory confirmation. The United Kingdom has emphasized veterinary antimicrobial use reduction and surveillance reporting, while Germany and France maintain advanced diagnostic and regulatory systems for food animal and companion animal health. Italy and Spain, with significant livestock and companion animal sectors, continue to integrate AST into stewardship and food safety programs. Russia's veterinary AST landscape is shaped by livestock production, regional laboratory modernization, and the need for surveillance of bacterial diseases relevant to animal health and food systems.

China's veterinary AST needs are driven by large-scale swine, poultry, aquaculture, and companion animal populations, alongside continued reforms in antimicrobial use governance and surveillance. India faces substantial demand due to its dairy, poultry, aquaculture, and companion animal sectors, with diagnostic standardization and laboratory access remaining priorities. Japan and South Korea have advanced veterinary healthcare systems, food safety programs, and AMR action plans that support structured testing and surveillance. Australia maintains strong biosecurity, antimicrobial stewardship, and veterinary diagnostic standards, with AST playing a central role in companion animal medicine, livestock health, and monitoring of resistant organisms relevant to public health.

Actionable Recommendations for Veterinary AST Leaders

Industry leaders should prioritize validated veterinary-specific AST workflows that align with recognized standards, quality control requirements, and clinically relevant interpretive criteria. Laboratories and diagnostic solution providers can improve adoption by offering species-appropriate antimicrobial panels, clear reporting formats, and decision support that distinguishes between clinical breakpoints, epidemiological cutoffs, and resistance markers. Investments in staff training, proficiency testing, and laboratory accreditation are essential to maintain confidence in susceptibility results.

Stakeholders should also strengthen One Health data interoperability. Veterinary AST results gain greater value when they can be connected to antimicrobial use records, farm management data, clinical outcomes, and public health surveillance systems while protecting data privacy and commercial confidentiality. Digital reporting tools should be designed to reduce administrative burden for veterinarians and laboratories, not add complexity.

For AI and rapid diagnostic implementation, leaders should follow a validation-first approach. New tools should be evaluated against reference phenotypic methods, tested across relevant animal species and bacterial pathogens, and monitored for performance drift. Commercial and institutional strategies should focus on practical use cases: faster treatment decisions, outbreak detection, resistance trend monitoring, improved antimicrobial panel selection, and stewardship compliance.

Research Methodology for Evidence-Based Veterinary AST Analysis

A robust research methodology for veterinary antimicrobial susceptibility testing analysis should combine secondary research, expert validation, and structured evidence review. Reliable sources include peer-reviewed veterinary microbiology publications, AMR surveillance reports, regulatory guidance, laboratory standards, national action plans, food safety authorities, and international One Health frameworks. Evidence should be assessed for geographic relevance, species specificity, pathogen coverage, test method validity, and consistency with current veterinary interpretive criteria.

Primary insights can be gathered through interviews with veterinary microbiologists, diagnostic laboratory directors, companion animal clinicians, livestock veterinarians, food safety specialists, regulatory experts, and antimicrobial stewardship professionals. Findings should be triangulated across diagnostic practice, regulatory requirements, clinical use cases, and surveillance needs. Methodological rigor requires exclusion of unsupported claims, clear distinction between phenotypic AST and molecular resistance detection, and careful review of whether cited breakpoints and test methods are appropriate for the animal species and pathogen under discussion.

The most credible analysis avoids speculative market sizing and instead focuses on verifiable adoption drivers, regulatory changes, technology readiness, laboratory quality systems, and evidence-based stewardship practices. Continuous monitoring is needed because veterinary AST evolves with new breakpoints, updated antimicrobial use rules, emerging resistance mechanisms, and advances in diagnostic automation and genomic epidemiology.

Conclusion: Veterinary AST as a One Health Imperative

Veterinary antimicrobial susceptibility testing is central to responsible animal healthcare, food safety, and One Health antimicrobial resistance control. As veterinary medicine moves away from empirical antimicrobial use and toward evidence-based treatment, AST provides the laboratory foundation for targeted therapy, resistance monitoring, and stewardship accountability. The field is being reshaped by standardized methods, veterinary-specific interpretive criteria, digital surveillance, rapid diagnostics, and carefully validated AI-enabled tools.

Regional and country-level adoption patterns vary according to diagnostic infrastructure, livestock intensity, companion animal healthcare maturity, regulation, and AMR surveillance priorities. Across all geographies, the strongest opportunities lie in improving laboratory quality, expanding access to validated testing, connecting AST data with stewardship programs, and ensuring that results are interpreted in ways that are clinically meaningful for animal species and production systems.

The future of veterinary AST will be defined by speed, standardization, interoperability, and trust. Stakeholders that invest in quality-assured diagnostics, One Health data integration, and responsible technology deployment will be best positioned to support veterinarians, producers, regulators, and public health systems in reducing antimicrobial resistance risks while safeguarding animal welfare and food security.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Antimicrobial Susceptibility Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Automated Systems
    • 7.2.1. MicroScan Systems
    • 7.2.2. PHOENIX Systems
    • 7.2.3. VITEK Systems
    • 7.2.4. WalkAway Systems
  • 7.3. Broth Microdilution
    • 7.3.1. Automated Broth Microdilution
    • 7.3.2. Manual Broth Microdilution
  • 7.4. Disk Diffusion
  • 7.5. Etest
  • 7.6. Molecular Methods
    • 7.6.1. LAMP-Based Methods
    • 7.6.2. NGS-Based Methods
    • 7.6.3. PCR-Based Methods
    • 7.6.4. QPCR-Based Methods

8. Veterinary Antimicrobial Susceptibility Testing Market, by Animal Type

  • 8.1. Introduction
  • 8.2. Aquaculture
  • 8.3. Companion Animals
  • 8.4. Equine
  • 8.5. Livestock
  • 8.6. Poultry

9. Veterinary Antimicrobial Susceptibility Testing Market, by Pathogen Type

  • 9.1. Introduction
  • 9.2. Fungi
  • 9.3. Gram-Negative Bacteria
  • 9.4. Gram-Positive Bacteria
  • 9.5. Mycobacteria

10. Veterinary Antimicrobial Susceptibility Testing Market, by Sample Type

  • 10.1. Introduction
  • 10.2. Blood
  • 10.3. Milk
  • 10.4. Swab
  • 10.5. Tissue
  • 10.6. Urine

11. Veterinary Antimicrobial Susceptibility Testing Market, by Product Type

  • 11.1. Introduction
  • 11.2. Instruments
    • 11.2.1. Automated Instruments
    • 11.2.2. Bench-Top Instruments
  • 11.3. Kits & Reagents
    • 11.3.1. Consumables
    • 11.3.2. Reagents
  • 11.4. Software & Services
    • 11.4.1. Data Management Software
    • 11.4.2. Technical Support & Consulting

12. Veterinary Antimicrobial Susceptibility Testing Market, by End User

  • 12.1. Introduction
  • 12.2. Pharma & Biotech
  • 12.3. Research Institutes
  • 12.4. Veterinary Diagnostic Laboratories
  • 12.5. Veterinary Hospitals & Clinics

13. Veterinary Antimicrobial Susceptibility Testing Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. Europe
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Africa
  • 13.6. Middle East

14. Veterinary Antimicrobial Susceptibility Testing Market, by Group

  • 14.1. NATO
  • 14.2. G7
  • 14.3. BRICS
  • 14.4. European Union
  • 14.5. ASEAN
  • 14.6. GCC

15. Veterinary Antimicrobial Susceptibility Testing Market, by Country

  • 15.1. China
  • 15.2. United States
  • 15.3. Japan
  • 15.4. India
  • 15.5. Germany
  • 15.6. United Kingdom
  • 15.7. Australia
  • 15.8. France
  • 15.9. South Korea
  • 15.10. Italy
  • 15.11. Canada
  • 15.12. Russia
  • 15.13. Brazil
  • 15.14. Mexico
  • 15.15. Spain

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Accelerate Diagnostics, Inc.
  • 17.2. Alifax S.r.l.
  • 17.3. Alveo Technologies, Inc.
  • 17.4. Becton, Dickinson and Company
  • 17.5. Bio-Rad Laboratories, Inc.
  • 17.6. Biogal Galed Laboratories
  • 17.7. Bioguard Corporation
  • 17.8. bioMerieux SA
  • 17.9. Bruker Corporation
  • 17.10. Condalab S.L.
  • 17.11. Creative Diagnostics
  • 17.12. Eurofins Scientific SE
  • 17.13. Hardy Diagnostics
  • 17.14. HiMedia Laboratories Private Limited
  • 17.15. Liofilchem S.r.l.
  • 17.16. Mast Group Ltd.
  • 17.17. Microbiologics, Inc.
  • 17.18. QIAGEN N.V.
  • 17.19. QuantaMatrix Inc.
  • 17.20. SSI Diagnostica A/S
  • 17.21. Thermo Fisher Scientific Inc.
  • 17.22. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MICROSCAN SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MICROSCAN SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MICROSCAN SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHOENIX SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHOENIX SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHOENIX SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VITEK SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VITEK SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VITEK SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL WALKAWAY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL WALKAWAY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL WALKAWAY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BROTH MICRODILUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BROTH MICRODILUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BROTH MICRODILUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATED BROTH MICRODILUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AUTOMATED BROTH MICRODILUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AUTOMATED BROTH MICRODILUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MANUAL BROTH MICRODILUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MANUAL BROTH MICRODILUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MANUAL BROTH MICRODILUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DISK DIFFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DISK DIFFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DISK DIFFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ETEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ETEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ETEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MOLECULAR METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LAMP-BASED METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LAMP-BASED METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LAMP-BASED METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NGS-BASED METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NGS-BASED METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NGS-BASED METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PCR-BASED METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PCR-BASED METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PCR-BASED METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL QPCR-BASED METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL QPCR-BASED METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL QPCR-BASED METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL EQUINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EQUINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL EQUINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LIVESTOCK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LIVESTOCK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LIVESTOCK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FUNGI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FUNGI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FUNGI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GRAM-NEGATIVE BACTERIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GRAM-NEGATIVE BACTERIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GRAM-NEGATIVE BACTERIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GRAM-POSITIVE BACTERIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GRAM-POSITIVE BACTERIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GRAM-POSITIVE BACTERIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MYCOBACTERIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MYCOBACTERIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MYCOBACTERIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MILK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MILK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MILK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SWAB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SWAB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SWAB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL URINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL URINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL AUTOMATED INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL AUTOMATED INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL AUTOMATED INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BENCH-TOP INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BENCH-TOP INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BENCH-TOP INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL KITS & REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL KITS & REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL KITS & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL TECHNICAL SUPPORT & CONSULTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL TECHNICAL SUPPORT & CONSULTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL TECHNICAL SUPPORT & CONSULTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PHARMA & BIOTECH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PHARMA & BIOTECH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PHARMA & BIOTECH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 215. NATO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. NATO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NATO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 218. NATO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)
  • TABLE 219. NATO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 220. NATO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. NATO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. NATO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. NATO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. NATO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 225. NATO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 227. NATO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. G7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. G7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. G7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 231. G7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)
  • TABLE 232. G7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 233. G7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. G7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. G7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 238. G7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 239. G7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 240. G7 VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. GCC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 281. GCC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. GCC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 283. GCC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)
  • TABLE 284. GCC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 285. GCC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. GCC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. GCC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. GCC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. GCC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 290. GCC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 291. GCC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 292. GCC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY MOLECULAR METHODS, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY BROTH MICRODILUTION, 2018-2032 (USD MILLION)

TABLE 3